InvestorsHub Logo
Followers 279
Posts 33068
Boards Moderated 0
Alias Born 11/14/2013

Re: ahp123 post# 186429

Friday, 08/17/2018 4:37:20 PM

Friday, August 17, 2018 4:37:20 PM

Post# of 718781
86% of 331 received DCVax-l.
54 of 99 placebo received DCVax-l.
There was likely little crossover impact, because only 3 patients in the entire trial received DCVax-l after recurrent surgery.
Also, many 100% psPD were excluded from the 331.
I personally believe, sadly, there are likely no original control patients still alive regardless if they crossed over or not.
I personally believe this wait is about QALY.
I personally think the current data collection will be the last.

Respect Risk. Conduct Your Own Due Diligence. Manage your assets wisely. Diversify.

Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent NWBO News